Current Issue
March 2026 — Volume 1, Issue 1
Table of Contents
-
-
- Clinical Research FDA Delay Forces Kezar Life Sciences to Close Its DoorsKeala Nakamura April 7, 2026
-
-
-
-
- Clinical Research Sarepta Therapeutics Shares Surge on Rare Disease Drug DataKeala Nakamura March 30, 2026
- Public Health Parenting Challenges in Primary Care: The GP Workforce GapMichael O'Connor March 30, 2026
-
- Medical Technology Radiologists Can't Spot AI Deepfake X-Rays, Study FindsPriya Patel March 29, 2026
- Clinical Research Electronic Marking Systems to Prevent Medical Exam ErrorsMichael O'Connor March 29, 2026
- Infectious Disease Pfizer Lyme Vaccine Shows 70% Efficacy But Misses Statistical GoalMichael O'Connor March 28, 2026
-
- Clinical Research FDA Approves Kresladi Gene Therapy for Rare LAD-1 DiseaseRobert Kim March 28, 2026
- Medical Technology Doctronic Raises $40M Series B to Expand AI Clinical CarePriya Patel March 27, 2026
-
- Clinical Research Novo Nordisk Faces Investor Pressure at 2026 Annual MeetingKeala Nakamura March 27, 2026
- Public Health 24 States Sue EPA Over Greenhouse Gas Endangerment RollbackMichael O'Connor March 26, 2026
-
Editor's Picks
- FDA Backs Domestic Drug Production to Counter China Keala Nakamura
- FDA Delay Forces Kezar Life Sciences to Close Its Doors Keala Nakamura
- FDA Delays Force Kezar Life Sciences to Shut Down Keala Nakamura
- BMJ Retracts PREVENT-TAHA8 Stem Cell Heart Failure Trial James Liu
Most Cited
- FDA Seeks New Powers Over Drug Ads in 2026 13 citations
- FDA Backs Domestic Drug Production to Counter China 42 citations
- FDA Delay Forces Kezar Life Sciences to Close Its Doors 5 citations
- FDA Delays Force Kezar Life Sciences to Shut Down 27 citations
- Trump Pushes Drug Pricing Legislation in 2026 17 citations
For Authors
Hawaii Medical Journal welcomes research submissions, case reports, and correspondence.
Submit a ManuscriptArchives
Browse past issuesHawaii Medical Journal Weekly
Top stories from Hawaii Medical Journal, delivered to your inbox every week. Free, no spam, unsubscribe anytime.